Pressure Ulcer — Knowledge and Practices of Preventing Pressure Ulcers
Citation(s)
Akyol AD Intervention studies for prevention of pressure ulcers in Turkey: a literature review. Int Nurs Rev. 2006 Dec;53(4):308-16. Review.
Dag Sucu G, Firat Kilic H Knowledge and attitudes of Turkish nursing students towards pressure injury prevention. J Tissue Viability. 2022 Feb;31(1):16-23. doi: 10.1016/j.jtv.2021.08.003. Epub 2021 Aug 25.
Dalli OE, Yildirim Y, Caliskan G, Girgin NK Reliability and validity of the Turkish version of pressure ulcer knowledge assessment tool-updated version (PUKAT 2.0). J Tissue Viability. 2022 Feb;31(1):52-57. doi: 10.1016/j.jtv.2021.08.001. Epub 2021 Aug 1
Kisacik ÖG, Sönmez M Pressure ulcers prevention: Turkish nursing students' knowledge and attitudes and influencing factors. J Tissue Viability. 2020 Feb;29(1):24-31. doi: 10.1016/j.jtv.2019.11.003. Epub 2019 Nov 10.
Reddy M, Gill SS, Rochon PA Preventing pressure ulcers: a systematic review. JAMA. 2006 Aug 23;296(8):974-84. Review.
Yilmazer T, Tuzer H, Inkaya B, Elcin M The impact of standardized patient interactions on nursing students' preventive interventions for pressure ulcers. J Tissue Viability. 2020 Feb;29(1):19-23. doi: 10.1016/j.jtv.2019.11.004. Epub 2019 Nov 15.
Comparison of Nursing Students' Knowledge Levels on Pressure Ulcer Prevention Using Flipped Learning and Traditional Learning Models: A Randomized Controlled Study
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
